相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Advances in mRNA-based drug discovery in cancer immunotherapy
Claudia Augusta Di Trani et al.
EXPERT OPINION ON DRUG DISCOVERY (2022)
ImmunoPeCa trial: Long-term outcome following intraperitoneal MOC31PE immunotoxin treatment in colorectal peritoneal metastasis
Ida S. Froysnes et al.
EJSO (2021)
A bispecific immunotoxin (IHPP) with a long half-life targeting HER2 and PDGFRβ exhibited improved efficacy against HER2-positive tumors in a mouse xenograft model
Rui Guo et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Novel EGFR-bispecific recombinant immunotoxin based on cucurmosin shows potent anti-tumor efficiency in vitro
Caiyun Zhang et al.
ONCOLOGY REPORTS (2021)
Immunotoxin IHP25-BT with low immunogenicity and off-target toxicity inhibits the growth and metastasis of trastuzumab-resistant tumor cells
Rui Guo et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Plant-made immunotoxin building blocks: A roadmap for producing therapeutic antibody-toxin fusions
M. Knoedler et al.
BIOTECHNOLOGY ADVANCES (2021)
Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review
Leah H. Biller et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Advancements in mRNA Encoded Antibodies for Passive Immunotherapy
Cailin E. Deal et al.
VACCINES (2021)
A Novel Bispecific Antibody Targeting CD3 and Lewis Y with Potent Therapeutic Efficacy against Gastric Cancer
Jie Chen et al.
BIOMEDICINES (2021)
Engineered mRNA and the Rise of Next-Generation Antibodies
Laura Sanz et al.
ANTIBODIES (2021)
Critical Issues in the Development of Immunotoxins for Anticancer Therapy
Ji-Sun Kim et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Immune stimulatory effect of anti-EpCAM immunotoxin - improved overall survival of metastatic colorectal cancer patients
Yvonne Andersson et al.
ACTA ONCOLOGICA (2020)
WNT7A Promotes EGF-Induced Migration of Oral Squamous Cell Carcinoma Cells by Activating beta-Catenin/MMP9-Mediated Signaling
Hui Xie et al.
FRONTIERS IN PHARMACOLOGY (2020)
Engineering of Ribosome-inactivating Proteins for Improving Pharmacological Properties
Jia-Qi Lu et al.
TOXINS (2020)
Selective Photokilling of Colorectal Tumors by Near-Infrared Photoimmunotherapy with a GPA33-Targeted Single-Chain Antibody Variable Fragment Conjugate
Danfeng Wei et al.
MOLECULAR PHARMACEUTICS (2020)
Efficacy and Safety of Regorafenib in Combination with Chemotherapy as Second-Line Treatment in Patients with Metastatic Colorectal Cancer: A Network Meta-Analysis and Systematic Literature Review
Xiaoyu Xie et al.
ADVANCES IN THERAPY (2020)
Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?
Olivier Gires et al.
CANCER AND METASTASIS REVIEWS (2020)
Immunogenicity of Immunotoxins Containing Pseudomonas Exotoxin A: Causes, Consequences, and Mitigation
Ronit Mazor et al.
FRONTIERS IN IMMUNOLOGY (2020)
Production of a Granulysin-Based, Tn-Targeted Cytolytic Immunotoxin Using Pulsed Electric Field Technology
Patricia Guerrero-Ochoa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Immunotoxin Screening System: A Rapid and Direct Approach to Obtain Functional Antibodies with Internalization Capacities
Shusei Hamamichi et al.
TOXINS (2020)
Targeting Receptors on Cancer Cells with Protein Toxins
Antonella Antignani et al.
BIOMOLECULES (2020)
The Role of Cholesterol on Triterpenoid Saponin-Induced Endolysosomal Escape of a Saporin-Based Immunotoxin
Wendy S. Smith et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
RNA-electroporated T cells for cancer immunotherapy
Fernanda Pohl-Guimaraes et al.
ONCOIMMUNOLOGY (2020)
Comprehensive review of targeted therapy for colorectal cancer
Yuan-Hong Xie et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Anti-KL-6/MUC1 monoclonal antibody reverses resistance to trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity by capping MUC1
Masashi Namba et al.
CANCER LETTERS (2019)
Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunity
Masanori Onda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Targeted human cytolytic fusion proteins at the cutting edge: harnessing the apoptosis-inducing properties of human enzymes for the selective elimination of tumor cells
Neelakshi Mungra et al.
Oncotarget (2019)
The Stromal and Immune Landscape of Colorectal Cancer Progression during Anti-EGFR Therapy
Irene Catalano et al.
CANCER CELL (2019)
Anti-Mesothelin Recombinant Immunotoxin Therapy for Colorectal Cancer
Adam Cerise et al.
CLINICAL COLORECTAL CANCER (2019)
Anti-tumoral potential of a human granulysin-based, CEA-targeted cytolytic immunotoxin
Raquel Ibanez-Perez et al.
ONCOIMMUNOLOGY (2019)
Targeting EGFR pathway in metastatic colorectal cancer- tumour heterogeniety and convergent evolution
Khurum Khan et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
A novel Carcinoembryonic Antigen (CEA)-Targeted Trimeric Immunotoxin shows significantly enhanced Antitumor Activity in Human Colorectal Cancer Xenografts
R. Lazaro-Gorines et al.
SCIENTIFIC REPORTS (2019)
Inclusion of a Furin Cleavage Site Enhances Antitumor Efficacy against Colorectal Cancer Cells of Ribotoxin α-Sarcin- or RNase T1-Based Immunotoxins
Javier Ruiz-de-la-Herran et al.
TOXINS (2019)
Biological Activities of Secretory RNases: Focus on Their Oligomerization to Design Antitumor Drugs
Giovanni Gotte et al.
FRONTIERS IN IMMUNOLOGY (2019)
Hosts for Hostile Protein Production: The Challenge of Recombinant Immunotoxin Expression
Stefania Zuppone et al.
BIOMEDICINES (2019)
Primary T cells for mRNA-mediated immunotoxin delivery
R. Eggers et al.
GENE THERAPY (2018)
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Robert J. Kreitman et al.
LEUKEMIA (2018)
Development of MGD007, a gpA33 x CD3-Bispecific DART Protein for T-Cell Immunotherapy of Metastatic Colorectal Cancer
Paul A. Moore et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Recombinant immunotoxins with albumin-binding domains have long half-lives and high antitumor activity
Junxia Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Strategies to Improve the Clinical Utility of Saporin-Based Targeted Toxins
Francesco Giansanti et al.
TOXINS (2018)
Fucosylated Antigens in Cancer: An Alliance toward Tumor Progression, Metastasis, and Resistance to Chemotherapy
Athanasios Blanas et al.
FRONTIERS IN ONCOLOGY (2018)
Bouganin, an Attractive Weapon for Immunotoxins
Massimo Bortolotti et al.
TOXINS (2018)
Immunotoxins Targeting B cell Malignancy-Progress and Problems With Immunogenicity
Daniel A. Vallera et al.
BIOMEDICINES (2018)
Updates in the Development of ImmunoRNases for the Selective Killing of Tumor Cells
Sandra Jordaan et al.
BIOMEDICINES (2018)
Human Granzyme B Based Targeted Cytolytic Fusion Proteins
Precious Hlongwane et al.
BIOMEDICINES (2018)
Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs
Anahita Javaheri et al.
NATURE MICROBIOLOGY (2017)
Immunotoxins in cancer therapy: Review and update
Bahman Akbari et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Novel recombinant immunotoxin of EGFR specific nanobody fused with cucurmosin, construction and antitumor efficiency in vitro
Cuimin Deng et al.
ONCOTARGET (2017)
Enhanced tumor-targeting selectivity by modulating bispecific antibody binding affinity and format valence
Yariv Mazor et al.
SCIENTIFIC REPORTS (2017)
Fungal Ribotoxins: A Review of Potential Biotechnological Applications
Miriam Olombrada et al.
TOXINS (2017)
Novel Treatment with Intraperitoneal MOC31PE Immunotoxin in Colorectal Peritoneal Metastasis: Results From the ImmunoPeCa Phase 1 Trial
Ida S. Froysnes et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Heterogeneous expression of A33 in colorectal cancer: possible explanation for A33 antibody treatment failure
Antuani R. Baptistella et al.
ANTI-CANCER DRUGS (2016)
A novel fully-human cytolytic fusion protein based on granzyme B shows in vitro cytotoxicity and ex vivo binding to solid tumors overexpressing the epidermal growth factor receptor
Judith Niesen et al.
CANCER LETTERS (2016)
Recent advances in cancer drug discovery targeting RAS
Candice Y. Wilson et al.
DRUG DISCOVERY TODAY (2016)
Epidermal growth factor receptor-targeted therapy in colorectal cancer
WeiDong Xu et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2016)
Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma
Avery D. Posey et al.
IMMUNITY (2016)
Immunogenicity of therapeutic recombinant immunotoxins
Ronit Mazor et al.
IMMUNOLOGICAL REVIEWS (2016)
A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein
Manal Amoury et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites
Farokh Dotiwala et al.
NATURE MEDICINE (2016)
Dual B- and T-cell de-immunization of recombinant immunotoxin targeting mesothelin with high cytotoxic activity
Ronit Mazor et al.
ONCOTARGET (2016)
A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy
Chiara D'Avino et al.
ONCOTARGET (2016)
Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers
Nathan Simon et al.
TOXINS (2016)
Augmenting the Efficacy of Immunotoxins and Other Targeted Protein Toxins by Endosomal Escape Enhancers
Hendrik Fuchs et al.
TOXINS (2016)
Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen
C. Fu et al.
HLA (2016)
Deciphering the Non-Equivalence of Serine and Threonine O-Glycosylation Points: Implications for Molecular Recognition of the Tn Antigen by an anti-MUC1 Antibody
Nuria Martinez-Saez et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin
Y. Andersson et al.
BRITISH JOURNAL OF CANCER (2015)
How Do Cytotoxic Lymphocytes Kill Cancer Cells?
Luis Martinez-Lostao et al.
CLINICAL CANCER RESEARCH (2015)
The coming of age of engineered multivalent antibodies
Natalia Nunez-Prado et al.
DRUG DISCOVERY TODAY (2015)
Preparation of an engineered safer immunotoxin against colon carcinoma based on the ribotoxin hirsutellinA
Jaime Tome-Amat et al.
FEBS JOURNAL (2015)
Death ligands and granulysin: mechanisms of tumor cell death induction and therapeutic opportunities
Luis Martinez-Lostao et al.
IMMUNOTHERAPY (2015)
Light-controlled endosomal escape of the novel CD133-targeting immunotoxin AC133-saporin by photochemical internalization - A minimally invasive cancer stem cell-targeting strategy
Monica Bostad et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Angiogenin Mutants as Novel Effector Molecules For the Generation of Fusion Proteins With Increased Cytotoxic Potential
Christian Cremer et al.
JOURNAL OF IMMUNOTHERAPY (2015)
In vivo potential of recombinant granulysin against human tumors
Sameer Al-Wasaby et al.
ONCOIMMUNOLOGY (2015)
Efficient in vivo antitumor effect of an immunotoxin based on ribotoxin α-sarcin in nude mice bearing human colorectal cancer xenografts
Jaime Tome-Amat et al.
SPRINGERPLUS (2015)
α-sarcin and RNase T1 based immunoconjugates: the role of intracellular trafficking in cytotoxic efficiency
Jaime Tome-Amat et al.
FEBS JOURNAL (2015)
Microencapsulation of therapeutic bispecific antibodies producing cells: immunotherapeutic organoids for cancer management
Laura Saenz del Burgo et al.
JOURNAL OF DRUG TARGETING (2015)
Glycosylation in cancer: mechanisms and clinical implications
Salome S. Pinho et al.
NATURE REVIEWS CANCER (2015)
Challenges in Antibody Development against Tn and Sialyl-Tn Antigens
Liliana R. Loureiro et al.
BIOMOLECULES (2015)
Perforin and granzymes: function, dysfunction and human pathology
Ilia Voskoboinik et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Granulysin induces apoptotic cell death and cleavage of the autophagy regulator Atg5 in human hematological tumors
Adriana Aporta et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Biodistribution and efficacy of [131I]A33scFv::CDy, a recombinant antibody-enzyme protein for colon cancer
Hossein Panjideh et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Combination of antibody targeting and PTD-mediated intracellular toxin delivery for colorectal cancer therapy
Meong Cheol Shin et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Relationship Between EGFR Expression, EGFR Mutation Status, and the Efficacy of Chemotherapy Plus Cetuximab in FLEX Study Patients with Advanced Non-Small-Cell Lung Cancer
Jean-Yves Douillard et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
EpCAM-Selective Elimination of Carcinoma Cells by a Novel MAP-Based Cytolytic Fusion Protein
Dmitrij Hristodorov et al.
MOLECULAR CANCER THERAPEUTICS (2014)
The novel EpCAM-targeting monoclonal antibody 3-17I linked to saporin is highly cytotoxic after photochemical internalization in breast, pancreas and colon cancer cell lines
Kaja Lund et al.
MABS (2014)
The development of immunoconjugates for targeted cancer therapy
Brandon G. Smaglo et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
The ErbB/HER family of protein-tyrosine kinases and cancer
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2014)
Microtubule-associated protein tau facilitates the targeted killing of proliferating cancer cells in vitro and in a xenograft mouse tumour model in vivo
D. Hristodorov et al.
BRITISH JOURNAL OF CANCER (2013)
Antibody Gene Therapy: Getting Closer to Clinical Application?
Irene Guijarro-Munoz et al.
CURRENT GENE THERAPY (2013)
A novel role for junctional adhesion molecule-A in tumor proliferation: Modulation by an anti-JAM-A monoclonal antibody
Liliane Goetsch et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Panitumumab-FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
Jean-Yves Douillard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Production and characterization of scFvA33T1, an immunoRNase targeting colon cancer cells
Jaime Tome-Amat et al.
FEBS JOURNAL (2012)
Production and characterization of a colon cancer-specific immunotoxin based on the fungal ribotoxin -sarcin
Nelson Carreras-Sangra et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2012)
Antibody-Based Immunotoxins for the Treatment of Cancer
Nurit Becker et al.
ANTIBODIES (2012)
The Tn Antigen-Structural Simplicity and Biological Complexity
Tongzhong Ju et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
An Immunoconjugate of Anti-CD24 and Pseudomonas Exotoxin Selectively Kills Human Colorectal Tumors in Mice
Shiran Shapira et al.
GASTROENTEROLOGY (2011)
124I-huA33 Antibody Uptake Is Driven by A33 Antigen Concentration in Tissues from Colorectal Cancer Patients Imaged by Immuno-PET
Joseph A. O'Donoghue et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Coevolution of activating and inhibitory receptors within mammalian carcinoembryonic antigen families
Robert Kammerer et al.
BMC BIOLOGY (2010)
Initial characterization of an immunotoxin constructed from domains II and III of cholera exotoxin
Robert Sarnovsky et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Factory neovessels: engineered human blood vessels secreting therapeutic proteins as a new drug delivery system
M. Compte et al.
GENE THERAPY (2010)
A33 Antigen-Deficient Mice Have Defective Colonic Mucosal Repair
Prue M. Pereira-Fantini et al.
INFLAMMATORY BOWEL DISEASES (2010)
ABT-737 Overcomes Resistance to Immunotoxin-Mediated Apoptosis and Enhances the Delivery of Pseudomonas Exotoxin-Based Proteins to the Cell Cytosol
Roberta Traini et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo
Y. Andersson et al.
BRITISH JOURNAL OF CANCER (2009)
Humanized immunotoxins: A new generation of immunotoxins for targeted cancer therapy
Mrudula Mathew et al.
CANCER SCIENCE (2009)
Current Constructs and Targets in Clinical Development for Antibody-Based Cancer Therapy
P. M. Deckert
CURRENT DRUG TARGETS (2009)
The Lewis-Y Carbohydrate Antigen is Expressed by Many Human Tumors and Can Serve as a Target for Genetically Redirected T cells Despite the Presence of Soluble Antigen in Serum
Jennifer A. Westwood et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Potent Control of Tumor Growth by CEA/CD3-bispecific Single-chain Antibody Constructs That Are Not Competitively Inhibited by Soluble CEA
Ralf Lutterbuese et al.
JOURNAL OF IMMUNOTHERAPY (2009)
The biology of cytotoxic cell granule exocytosis pathway: granzymes have evolved to induce cell death and inflammation
Julian Pardo et al.
MICROBES AND INFECTION (2009)
In Vivo Tumor Targeting and Imaging with Engineered Trivalent Antibody Fragments Containing Collagen-Derived Sequences
Angel M. Cuesta et al.
PLOS ONE (2009)
A33 antigen displays persistent surface expression
Margaret E. Ackerman et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
From ImmunoToxins to ImmunoRNases
Claudia Lorenzo et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2008)
Antibody-targeted RNase fusion proteins (ImmunoRNases) for cancer therapy
Juergen Krauss et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2008)
An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes
Masanori Onda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Granzyme B-induced cell death exerted by ex vivo CTL:: discriminating requirements for cell death and some of its signs
J. Pardo et al.
CELL DEATH AND DIFFERENTIATION (2008)
A bispecific recombinant cytotoxin (DTEGF13) targeting human interleukin-13 and epidermal growth factor receptors in a mouse xenograft model of prostate cancer
Brad J. Stish et al.
CLINICAL CANCER RESEARCH (2007)
A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen
Andrew M. Scott et al.
CLINICAL CANCER RESEARCH (2007)
Increasing anticarcinoma activity of an anti-erbB2 recombinant immunotoxin by the addition of an anti-EpCAM sFv
Brad J. Stish et al.
CLINICAL CANCER RESEARCH (2007)
Immunotoxin treatment of cancer
Ira Pastan et al.
ANNUAL REVIEW OF MEDICINE (2007)
Fungal ribotoxins: molecular dissection of a family of natural killers
Javier Lacadena et al.
FEMS MICROBIOLOGY REVIEWS (2007)
Characterization of the B cell epitopes associated with a truncated form of Pseudomonas exotoxin (PE38) used to make immunotoxins for the treatment of cancer patients
Masanori Onda et al.
JOURNAL OF IMMUNOLOGY (2006)
In vitro and in vivo characterization of 177Lu-huA33 A radioimmunoconjugate against colorectal cancer
Ylva Almqvist et al.
NUCLEAR MEDICINE AND BIOLOGY (2006)
The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer
Tracy R. Daniels et al.
CLINICAL IMMUNOLOGY (2006)
CEACAMs: their role in physiology and pathophysiology
Katharina Kuespert et al.
CURRENT OPINION IN CELL BIOLOGY (2006)
Enhanced antiangiogenic therapy with antibody-collagen XVIII NCl domain fusion proteins engineered to exploit matrix remodeling events
Victor J. Sanchez-Arevalo Lobo et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Cholesterol in negatively charged lipid bilayers modulates the effect of the antimicrobial protein granulysin
Hanna Barman et al.
JOURNAL OF MEMBRANE BIOLOGY (2006)
A dimeric angiogenin immunofusion protein mediates selective toxicity towards CD22+ tumor cells
MAE Arndt et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas
G von Minckwitz et al.
BREAST CANCER RESEARCH (2005)
Regression of cutaneous tumor lesions in patients intratumorally injected with a recombinant single-chain antibody-toxin targeted to ErbB2/HER2
M Azemar et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines
MJ Duffy et al.
EUROPEAN JOURNAL OF CANCER (2003)
A33scFv-cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapy
PM Deckert et al.
BRITISH JOURNAL OF CANCER (2003)
Granulysin crystal structure and a structure-derived lytic mechanism
DH Anderson et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Analysis of the regulation of the A33 antigen gene reveals intestine-specific mechanisms of gene expression.
CN Johnstone et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study
CJA Punt et al.
LANCET (2002)
Single-chain antibody-based gene therapy: inhibition of tumor growth by in situ production of phage-derived human antibody fragments blocking functionally active sites of cell-associated matrices
L Sanz et al.
GENE THERAPY (2002)
Primary polyclonal human T lymphocytes targeted to carcino-embryonic antigens and neural cell adhesion molecule tumor antigens by CD3 zeta-based chimeric immune receptors
DE Gilham et al.
JOURNAL OF IMMUNOTHERAPY (2002)
A role of the mitochondrial apoptosis-inducing factor in granulysin-induced apoptosis
J Pardo et al.
JOURNAL OF IMMUNOLOGY (2001)
A distinct pathway of cell-mediated apoptosis initiated by granulysin
AA Kaspar et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
